Identification and characterization of circulating variants of CXCL12 from human plasma: Effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells

Stem Cells and Development

Volumn 23, Issue 16, 2014, Pages 1959-1974

  Richter, Rudolf ^a,b   Jochheim Richter, Andrea ^a,b   Ciuculescu, Felicia ^a   Kollar, Katarina ^a   Seifried, Erhard ^a   Forssmann, Ulf ^b   Verzijl, Dennis ^c   Smit, Martine J ^c   Blanchet, Xavier ^d   Von Hundelshausen, Philipp ^d   Weber, Christian ^d   Forssmann, Wolf Georg ^b   Henschler, Reinhard ^a,e  

^a Institute of Transfusion Medicine and Immune Hematology   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; GLYCOSAMINOGLYCAN; LOW MOLECULAR WEIGHT HEPARIN; CXCL12 PROTEIN, HUMAN; PROTEIN BINDING; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MIGRATION; CHEMOTAXIS; COLONY FORMING UNIT; DISSOCIATION CONSTANT; GLYCOSAMINOGLYCAN METABOLISM; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SURFACE PLASMON RESONANCE; THROMBOCYTE; ANIMAL; BLOOD; CALCIUM SIGNALING; CELL CULTURE; DBA MOUSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN PROCESSING;

ANIMALS; BLOOD PLATELETS; CALCIUM SIGNALING; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES; MICE, INBRED DBA; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS;

EID: 84905637489     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0524     Document Type: Article

References (55)

1. Lapid K, C Glait-Santar, S Gur-Cohen, J Canaani, O Kollet and T Lapidot. (2012). Egress and mobilization of hematopoietic stem and progenitor cells: a dynamic multi-facet process. StemBook [Internet]. Cambridge, MA: Harvard Stem Cell Institute, 2008-2012.
2. Bonig H and T Papayannopoulou. (2013). Hematopoietic stem cell mobilization: updated conceptual renditions. Leukemia 27:24-31.
3. Kim CH, W Wu, M Wysoczynski, A Abdel-Latif, M Sunkara, A Morris, M Kucia, J Ratajczak and MZ Ratajczak. (2012). Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 26:106-116.
4. Ratajczak MZ, CH Kim, A Abdel-Latif, G Schneider, M Kucia, AJ Morris, MJ Laughlin and J Ratajczak. (2012). A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 26:63-72.
5. Sahin AO and M Buitenhuis. (2012). Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells. Cell Adh Migr 6:39-48.
6. Christopher MJ, F Liu, MJ Hilton, F Long and DC Link. (2009). Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokineinduced mobilization. Blood 114:1331-1339.
7. Proudfoot AE. (2006). The biological relevance of chemokineproteoglycan interactions. Biochem Soc Trans 34:422-426.
8. Blanchet X, M Langer, C Weber, RR Koenen and P von Hundelshausen. (2012). Touch of chemokines. Front Immunol 3:175-193.
9. Verzijl D, S Storelli, DJ Scholten, L Bosch, TA Reinhart, DN Streblow, CP Tensen, CP Fitzsimons, GJ Zaman, et al. (2008). Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors. J Pharmacol Exp Ther 325:544-555.
10. Richter R, R Bistrian, S Escher, W-G Forssmann, J Vakili, R Henschler, N Spodsberg, A Frimpong-Boateng and U Forssmann. (2005). Quantum proteolytic activation of chemokine CCL15 by neutrophil granulocytes modulates mononuclear cell adhesiveness. J Immunol 175:1599-1608.
11. Amara A, O Lorthioir, A Valenzuela, A Magerus, M Thelen, M Montes, JL Virelizier, M Delepierre, F Baleux, H Lortat-Jacob and F Arenzana-Seisdedos. (1999). Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 274:23916-23925.
12. Christopherson KW, 2nd, G Hangoc, CR Mantel and HE Broxmeyer. (2004). Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305:1000-1003.
13. Nomura S, N Inami, S Kanazawa, T Iwasaka and S Fukuhara. (2004). Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells 22:696-703.
14. Hattori K, B Heissig, K Tashiro, T Honjo, M Tateno, JH Shieh, NR Hackett, MS Quitoriano, RG Crystal, S Rafii and MA Moore. (2001). Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97:3354-3360.
15. Frenette PS and L Weiss. (2000). Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms. Blood 96:2460-2468.
16. Albanese P, D Caruelle, G Frescaline, J Delbe, L Petit-Cocault, E Huet, N Charnaux, G Uzan, D Papy-Garcia and J Courty. (2009). Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights. Exp Hematol 37:1072-1083.
17. Dar A, A Schajnovitz, K Lapid, A Kalinkovich, T Itkin, A Ludin, WM Kao, M Battista, M Tesio, et al. (2011). Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Leukemia 25:1286-1296.
18. Lambeir AM, P Proost, C Durinx, G Bal, K Senten, K Augustyns, S Scharpe, J Van Damme and I De Meester. (2001). Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 276:29839-29845.
19. Antonsson B, P De Lys, V Dechavanne, L Chevalet and U Boschert. (2010). In vivo processing of CXCL12alpha/SDF-1alpha after intravenous and subcutaneous administration to mice. Proteomics 10:4342-4351.
20. Ponomaryov T, A Peled, I Petit, RS Taichman, L Habler, J Sandbank, F Arenzana-Seisdedos, A Magerus, A Caruz, et al. (2000). Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106:1331-1339.
21. Swenson ES, R Kuwahara, DS Krause and ND Theise. (2008). Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration. Liver Int 28:308-318.
22. Kim JH, A Kolozsvary, KA Jenrow and SL Brown. (2012). Plerixafor, a CXCR4 antagonist, mitigates skin radiationinduced injury in mice. Radiat Res 178:202-206.
23. Zhang J, Gong JF, Zhang W, Zhu WM and Li JS. (2008). Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 15:585-594.
24. Kollet O, A Spiegel, A Peled, I Petit, T Byk, R Hershkoviz, E Guetta, G Barkai, A Nagler and T Lapidot. (2001). Rapid and efficient homing of human CD34(+)CD38(-/low) CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 97:3283-3291.
25. Ding L and SJ Morrison. (2013). Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495:231-235.
26. Todeschini M, D Macconi, NG Fernandez, M Ghilardi, A Anabaya, E Binda, M Morigi, D Cattaneo, E Perticucci, G Remuzzi and M Noris. (2002). Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. Am J Kidney Dis 40:783-793.
27. Bonig H and T Papayannopoulou. (2012). Mobilization of hematopoietic stem/progenitor cells: general principles and molecular mechanisms. Methods Mol Biol 904:1-14.
28. Levesque JP, J Hendy, Y Takamatsu, PJ Simmons and LJ Bendall. (2003). Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 111:187-196.
29. Marquez-Curtis LA, AR Turner, S Sridharan, MZ Ratajczak and A Janowska-Wieczorek. (2011). The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes. Stem Cell Rev 7:590-607.
30. Levesque JP, Y Takamatsu, SK Nilsson, DN Haylock and PJ Simmons. (2001). Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98:1289-1297.
31. Petit I, M Szyper-Kravitz, A Nagler, M Lahav, A Peled, L Habler, T Ponomaryov, RS Taichman, F Arenzana-Seisdedos, et al. (2002). G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687-694.
32. Levesque JP, F Liu, PJ Simmons, T Betsuyaku, RM Senior, C Pham and DC Link. (2004). Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 104:65-72.
33. Steinl C, M Essl, TD Schreiber, K Geiger, L Prokop, S Stevanovic, O Potz, H Abele, JT Wessels, WK Aicher and G Klein. (2013). Release of matrix metalloproteinase-8 during physiological trafficking and induced mobilization of human hematopoietic stem cells. Stem Cells Dev 22:1307-1318.
34. McQuibban GA, S Butler, JH Gong, L Bendall, C Power, I Clark-Lewis and CM Overall. (2001). Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276:43503-43508.
35. Levesque JP, J Hendy, Y Takamatsu, B Williams, IG Winkler and PJ Simmons. (2002). Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 30:440-449.
36. Vandooren J, PE Van den Steen and G Opdenakker. (2013). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol 48:222-272.
37. Shimanovich I, S Mihai, GJ Oostingh, TT Ilenchuk, EB Brocker, G Opdenakker, D Zillikens and C Sitaru. (2004). Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 204:519-527.
38. Jackson PL, X Xu, L Wilson, NM Weathington, JP Clancy, JE Blalock and A Gaggar. (2010). Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Mol Med 16:159-166.
39. Ponte AL, T Ribeiro-Fleury, V Chabot, F Gouilleux, A Langonne, O Herault, P Charbord and J Domenech. (2012). Granulocyte-colony-stimulating factor stimulation of bone marrow mesenchymal stromal cells promotes CD34+ cell migration via a matrix metalloproteinase-2-dependent mechanism. Stem Cells Dev 21:3162-3172.
40. Denoyer A, D Godefroy, I Celerier, J Frugier, J Degardin, JK Harrison, F Brignole-Baudouin, S Picaud, F Baleux, et al. (2012). CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension. PLoS One 7:e37873-e37884.
41. Jinquan T, S Quan, HH Jacobi, C Jing, A Millner, B Jensen, HO Madsen, LP Ryder, A Svejgaard, et al. (2000). CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood 96:1230-1238.
42. Wiesner O, RD Litwiller, AM Hummel, MA Viss, CJ McDonald, DE Jenne, DN Fass and U Specks. (2005). Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett 579:5305-5312.
43. Raymond WW, NN Trivedi, A Makarova, M Ray, CS Craik and GH Caughey. (2010). How immune peptidases change specificity: cathepsin G gained tryptic function but lost efficiency during primate evolution. J Immunol 185:5360-5368.
44. Davis DA, KE Singer, SM De La Luz, M Narazaki, F Yang, HM Fales, R Yarchoan and G Tosato. (2005). Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood 105:4561-4568.
45. Marquez-Curtis L, A Jalili, K Deiteren, N Shirvaikar, AM Lambeir and A Janowska-Wieczorek. (2008). Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor- 1alpha: another player in hematopoietic stem/progenitor cell mobilization? Stem Cells 26:1211-1220.
46. Staudt ND, WK Aicher, H Kalbacher, S Stevanovic, AK Carmona, M Bogyo and G Klein. (2010). Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts. Haematologica 95:1452-1460.
47. Staudt ND, A Maurer, B Spring, H Kalbacher, WK Aicher and G Klein. (2012). Processing of CXCL12 by different osteoblast-secreted cathepsins. Stem Cells Dev 21:1924-1935.
48. Lin JH, M Garand, B Zagorac, SL Schadinger, C Scipione, ML Koschinsky and MB Boffa. (2011). Identification of human thrombin-activatable fibrinolysis inhibitor in vascular and inflammatory cells. Thromb Haemost 105:999-1009.
49. Loetscher P, JH Gong, B Dewald, M Baggiolini and I Clark-Lewis. (1998). N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 273:22279-22283.
50. Murphy JW, Y Cho, A Sachpatzidis, C Fan, ME Hodsdon and E Lolis. (2007). Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem 282:10018-10027.
51. Ohnishi Y, T Senda, N Nandhagopal, K Sugimoto, T Shioda, Y Nagal and Y Mitsui. (2000). Crystal structure of recombinant native SDF-1alpha with additional mutagenesis studies: an attempt at a more comprehensive interpretation of accumulated structure-activity relationship data. J Interferon Cytokine Res 20:691-700.
52. Murphy JW, H Yuan, Y Kong, Y Xiong and EJ Lolis. (2010). Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family. Proteins 78:1331-1337.
53. Veldkamp CT, C Seibert, FC Peterson, NB De la Cruz, JC Haugner, III, H Basnet, TP Sakmar and BF Volkman. (2008). Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci Signal 1:ra4-
54. Ziarek JJ, CT Veldkamp, F Zhang, NJ Murray, GA Kartz, X Liang, J Su, JE Baker, RJ Linhardt and BF Volkman. (2013). Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. J Biol Chem 288:737-746.
55. Netelenbos T, S Zuijderduijn, J van den Born, FL Kessler, S Zweegman, PC Huijgens and AM Drager. (2002). Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leukoc Biol 72:353-362.